EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion

Wenbei Peng iD, Linlin Ye, Qianqian Xue, Xiaoshan Wei, Zihao Wang, Xuan Xiang, Siyu Zhang, Pei Zhang, Haolei Wang, Qiong Zhou

Cells · 10.01.2023 · 12 (2) · 273

DOI: 10.3390/cells12020273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 10.01.2023. Verfasst von Wenbei Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 43…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Circular RNAs (circRNAs) have been found to have significant impacts on non-small cell lung cancer (NSCLC) progression through various mechanisms. However, the mechanism of circRNAs modulating tumor immune evasion in NSCLC has yet to be well-revealed. Materials and Methods: Through analyzing the expression profiles of circRNAs in NSCLC tissues, RNA FISH, pull-down assay, mass spectrometry analysis, and RIP, circCRIM1 was identified, and its interaction with IGF2BP1 was confirmed. The effects of circCRIM1 on modulating tumor immune evasion were explored via co-culture in vitro and in tumor xenograft models. Subsequently, we evaluated the regulatory effects of circCRIM1 on IGF2BP1 and screened its target genes through RNA sequencing. Finally, we explored the underlying molecular mechanisms that circCRIM1 could regulate the stability of target mRNA. Results: circCRIM1 was downregulated in NSCLC, and its expression was positively correlated with favorable prognoses. Furthermore, circCRIM1 was more stable than its linear transcript and was mainly localized in the cytoplasm. Mechanistically, circCRIM1 destabilized HLA-F mRNA via competitive binding to IGF2BP1. Importantly, the overexpression of circCRIM1 suppressed the immune evasion of NSCLC and promoted the expressions of Granzyme B, IFN-γ, and TNF-α of CD8+ T and NK cell in vitro co-culture assays and tumor xenograft models.

Conclusions

This study identifies circCRIM1 as a new tumor suppressor that inhibits tumor immune evasion through a competitive combination with IGF2BP1 to destabilize HLA-F mRNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansRNA, CircularImmune EvasionCell Line, TumorRNA, Messenger

Stichwörter der Autor:innen

NSCLCcircular RNAsimmune evasion

Substanzen

RNA, CircularRNA, Messenger

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

ORCID-Profile: Wenbei Peng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Peng, W., Ye, L., Xue, Q., Wei, X., Wang, Z., Xiang, X., Zhang, S., Zhang, P., Wang, H., & Zhou, Q. (2023). Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells, 12(2), 273. https://doi.org/10.3390/cells12020273

Vancouver

Peng W, Ye L, Xue Q, Wei X, Wang Z, Xiang X, et al. Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. Cells. 2023;12(2):273. doi:10.3390/cells12020273

BibTeX
@article{Peng2023,
  author = {Peng, Wenbei and Ye, Linlin and Xue, Qianqian and Wei, Xiaoshan and Wang, Zihao and Xiang, Xuan and Zhang, Siyu and Zhang, Pei and Wang, Haolei and Zhou, Qiong},
  title = {Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {2},
  pages = {273},
  doi = {10.3390/cells12020273}
}
Kostenlos starten →